Xilio Therapeutics (XLO) Institutional Ownership $1.32 +0.05 (+3.94%) (As of 11/1/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)CurrentInstitutional OwnershipPercentage54.29%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$107.10KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$2.20M Get XLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XLO Institutional Buying and Selling by Quarter Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Xilio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2024XTX Topco Ltd33,289$32K0.0%N/A0.076% 8/9/2024Renaissance Technologies LLC295,000$280K0.0%+18.3%0.799% 5/6/2024Atlas Venture Life Science Advisors LLC992,912$1.07M0.1%-64.0%2.690% 4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087% 2/15/2024Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481% 11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047% 8/15/2022Laurion Capital Management LP142,900$417K0.0%N/A0.520% 7/27/2022 Bailard Inc.36,632$107K0.0%N/A0.133% 5/16/2022Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567% 5/12/2022Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594% 2/15/2022Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109% 2/14/2022Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078% 2/14/2022Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113% 2/14/2022Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791% 2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038% 2/9/2022AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504% 2/8/2022Northern Trust Corp63,034$1.01M0.0%N/A0.236% 2/7/2022Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803% 2/7/2022 RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406% 2/2/2022 New York State Common Retirement Fund5,568$89K0.0%N/A0.021% (Data available from 1/1/2016 forward) XLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XLO shares? During the previous two years, the following institutional investors and hedge funds held shares of Xilio Therapeutics shares: Atlas Venture Life Science Advisors LLC ($1.07M), Octagon Capital Advisors LP ($982K), Renaissance Technologies LLC ($280K), Ergoteles LLC ($38K), and XTX Topco Ltd ($32K), PFG Investments LLC ($32K).Learn more on XLO's institutional investors. What percentage of Xilio Therapeutics stock is owned by institutional investors? 54.29% of Xilio Therapeutics stock is owned by institutional investors. Learn more on XLO's institutional investor holdings. Which institutional investors have been buying Xilio Therapeutics stock? The following institutional investors have purchased Xilio Therapeutics stock in the last 24 months: Renaissance Technologies LLC ($45.55K), XTX Topco Ltd ($33.29K), and PFG Investments LLC ($30K). How much institutional buying is happening at Xilio Therapeutics? Institutional investors have bought a total of 108,843 shares in the last 24 months. This purchase volume represents approximately $107.10K in transactions. Which Xilio Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Atlas Venture Life Science Advisors LLC ($1.77M), Octagon Capital Advisors LP ($533.50K), and Ergoteles LLC ($4.61K). How much institutional selling is happening at Xilio Therapeutics? Institutional investors have sold a total of 2,304,539 shares in the last 24 months. This volume of shares sold represents approximately $2.21M in transactions. Related Companies ENTA Institutional Ownership TSVT Institutional Ownership NKTR Institutional Ownership XBIT Institutional Ownership PYXS Institutional Ownership MRSN Institutional Ownership ETON Institutional Ownership TRVI Institutional Ownership NKTX Institutional Ownership LFCR Institutional Ownership This page (NASDAQ:XLO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xilio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
